Cystic fibrosis year in review 2022.

Abstract excerpt

Remarkable medical advancements have been made for people with cystic fibrosis (CF) in recent years, with an abundance of research continuing to be conducted worldwide. With concern for limitations in access to highly effective CFTR modulators, as well as the recent Coronavirus Disease-19 pandemic, there has been a consistent effort to understand and improve CF screening, disease burden, diagnosis, and...

Topics

Join the communities discussing this publication.

• Cost of Illness
• COVID-19
• Cystic Fibrosis
• Cystic Fibrosis Transmembrane Conductance Regulator
• Mutation